611 W. Union Street
Benson, AZ 85602
(520) 586-0800

member support line
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...

Medical Disorders
Basic InformationLookupsLatest News
Most Newborns of COVID-19-Infected Moms Fare WellCOVID Antibodies Found in Less Than 10% of AmericansCOVID-19 Patients Rarely Survive Cardiac Arrest: StudyLow Vitamin D Levels Tied to Higher Odds for Severe COVIDKids Much Less Prone to Coronavirus Infection Than Adults: Study'Silent' COVID-19 Produces as Much Virus as in Patients With Symptoms: StudyImmune System Clues to Why COVID Is Easier on KidsU.S. Coronavirus Cases Top 7 MillionAccuracy of COVID-19 Antibody Tests Varies Widely, Study FindsAmerica's COVID Pandemic Is Now Skewing YoungerEven If Hips, Legs Slim Down, Belly Fat Remains a Health DangerAfter COVID-19 Exposure, When Can Young Athletes Resume Play?Kids Who Need Steroids Face Risk of Diabetes, Other Ills9 in 10 Americans Not Yet Immune to COVID, CDC Director SaysCommon Heart Defect Limits Exercise Ability: StudyBlood Test Could Spot Those at Highest Risk for Severe COVID-19Singing Without a Face Mask Can Spread COVID-19Could Zinc Help Fight COVID-19?U.S. COVID Death Toll Hits 200,000 as Cases Climb in 22 States4 Out of 5 People With COVID-19 Will Develop Symptoms: StudyMany Health Care Workers Who Have Coronavirus Don't Have Symptoms: StudyAHA News: Cluster of Risky Conditions That Can Lead To Heart Disease Is Rising in Hispanic AdultsMinorities Hit Hardest When COVID Strikes Nursing HomesAvoid the 'Twindemic:' Get Your Flu Shot NowCertain Cancer Treatments May Heighten Danger From COVID-19Homemade Masks Do a Great Job Blocking COVID-19Having Flu and COVID Doubles Death Risk in Hospitalized PatientsGuard Yourself Against the Health Dangers of Wildfire SmokeLife Expectancy Could Decline Worldwide Due to COVID-19Potential COVID-19 Drug Could Increase Heart Risk: StudyU.S. COVID Death Toll Nears 200,000, While Cases Start to Climb AgainCDC Reverses COVID Test Guideline After ControversyAs Schools Reopen, Many Students, Staff Live With High-Risk Family MemberCOVID-19 Poses Added Risk for People With Addiction Disorders: StudyGetting a Hip Replacement? Choice of Hospital Can Be CrucialAlmost 90,000 Young American Adults Will Get Cancer This Year: ReportAnother Rapid COVID-19 Test Shows PromiseDetails Emerge on Unexplained Illness in AstraZeneca COVID Vaccine TrialRising Obesity Levels Put Americans at Risk During Pandemic: CDCMore Pets May Be Getting COVID-19 Than RealizedWildfire Smoke Poses Special Threat to People With AsthmaCOVID-19 Prevention Might Translate Into Record Low Flu Rates: CDCFor Stroke Survivors, Timely Rehab Has Been Jeopardized During PandemicCOVID-19 Has Taken a Toll on Organ DonationCOVID Conflicts Are Putting Big Strains on RelationshipsCoronavirus Vaccine Plan for Americans AnnouncedParkinson's Ups the Odds for Dangerous Falls, But Prevention Is KeyPregnant Women With COVID-19 at High Risk for ComplicationsCompanion Drug Might Help Prevent Kidney Complications of LupusAHA News: Making Sense of Cholesterol – the Good, the Bad and the Dietary
Questions and AnswersLinksBook Reviews
Related Topics

Men's Health
Women's Health

Small Study Supports Donor Plasma Therapy for Severe COVID-19

HealthDay News
by By E.J. Mundell
HealthDay Reporter
Updated: Sep 15th 2020

new article illustration

TUESDAY, Sept. 15, 2020 (HealthDay News) -- Using the donated blood plasma of COVID-19 survivors to treat patients in the throes of severe coronavirus illness has met with some controversy. But a small new study suggests it could have real merit.

The study of 39 patients with severe COVID-19 who were treated at one New York City hospital found the treatment appeared to bump up survival, researchers said.

Plasma is the component of blood that contains immune system antibodies. So-called "convalescent plasma" from COVID-19 survivors is rich in antibodies against SARS-CoV-2, and it's thought that infusing the plasma into COVID-19 patients might help them battle their illness.

On Aug. 23, the U.S. Food and Drug Administration made the unusual and controversial move of granting emergency approval for the use of convalescent plasma for COVID-19 -- despite a lack of proof of efficacy from randomized clinical trials.

Those trials are underway, but in the meantime anecdotal evidence has suggested that at the very least, the therapy is safe, one expert said.

"I cannot think of one shred of data that I have seen that would suggest harm," said Dr. Liise-anne Pirofski, chair of biomedical research at the Albert Einstein College of Medicine and Montefiore Medical Center, in New York City.

But does convalescent therapy actually help speed recovery from severe COVID-19?

To help find out, a team led by Dr. Nicole Bouvier, of Mount Sinai Hospital in New York City, tracked outcomes for 39 patients hospitalized with COVID-19. They were all very ill: By the time these patients were given a donor plasma transfusion, 87% required supplemental oxygen to breathe, and 10% were on ventilators.

Outcomes for the 39 transfused patients were compared to those of 156 other COVID-19 patients with similar symptoms and medical histories who had not received the experimental treatment.

Reporting Sept. 15 in the journal Nature Medicine, Bouvier's group concluded that "convalescent plasma is potentially effective against COVID-19."

The researchers found that by day 14 after receiving the plasma therapy, 18% of patients still required oxygen supplementation, compared to 28% of those in the "control" group who hadn't gotten the infusion.

By the end of the study in May, 13% of people who got convalescent plasma had died compared with 24% of those who hadn't, the study authors said.

Still, the study was not a large, randomized clinical trial, Bouvier's group said, so the findings are not definitive. "Additional studies are needed to confirm these findings and draw more definitive conclusions about the efficacy of convalescent plasma transfusion for the treatment of COVID-19 in different populations," the team concluded.

Pirofski agreed. "What I think everybody agrees on is the gaps of knowledge that exist can best be addressed by high-quality trials," she said.

More information

The American Society of Hematology has more about convalescent plasma and COVID-19.